|
000
| 01738nam 2200301za 4500 |
|---|
| 001 | 9.818011 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107142620 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 160728s2016 onc ob f000 0 eng d |
|---|
| 020 | |a978-0-660-05478-0 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP40-157/2016E-PDF |
|---|
| 245 | 00|aUpdated recommendations on human papillomavirus (HPV) vaccines |h[electronic resource] : |b9-valent HPV vaccine and clarification of minimum intervals between doses in the HPV immunization schedule. |
|---|
| 246 | 1 |iAt head of title: |aAdvisory committee statement (ACS) - National Advisory Committee on Immunization (NACI) |
|---|
| 246 | 30|a9-valent HPV vaccine and clarification of minimum intervals between doses in the HPV immunization schedule |
|---|
| 260 | |aOttawa : |bPublic Health Agency of Canada, |c2016. |
|---|
| 300 | |a55 p. |
|---|
| 500 | |aIssued also in French under title: Recommandations mises à jour sur les vaccins contre le virus du papillome humain (VPH) : vaccin nonavalent contre le VPH et précisions sur les intervalles minimums entre les doses dans le calendrier d'immunisation contre le VPH. |
|---|
| 504 | |aIncludes bibliographical references (p. 11). |
|---|
| 692 | 07|2gccst|aSexually transmitted diseases |
|---|
| 692 | 07|2gccst|aImmunization |
|---|
| 710 | 1 |aCanada. |bNational Advisory Committee on Immunization. |
|---|
| 710 | 2 |aPublic Health Agency of Canada. |
|---|
| 775 | 08|tRecommandations mises à jour sur les vaccins contre le virus du papillome humain (VPH) |w(CaOODSP)9.818014 |
|---|
| 794 | |tUpdated recommendations on human papillomavirus (HPV) vaccines |w(CaOODSP)9.833902 |
|---|
| 856 | 40|qPDF|s1.18 MB|uhttps://publications.gc.ca/collections/collection_2016/aspc-phac/HP40-157-2016-eng.pdf |
|---|